Cardiovascular problems for two types of Diabetes medicines
Description
A comparison of cardiovascular problems for Rosiglitazone and Pioglitazone.
Usage
avandia
Format
A data frame with 227571 observations on the following 2 variables.
- treatment
a factor with levels
Pioglitazone
andRosiglitazone
- cardiovascular_problems
a factor with levels
no
andyes
Source
D.J. Graham et al. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. In: JAMA 304.4 (2010), p. 411. issn: 0098-7484.